Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
1(25.0%)
Phase 4
1(25.0%)
N/A
1(25.0%)
Phase 1
1(25.0%)
4Total
Phase 2(1)
Phase 4(1)
N/A(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01817634Not ApplicableCompleted

ω3 LCPUFAs for Healthy Growth and Development of Infants and Young Children in Southwest Ethiopia

Role: collaborator

NCT01820988Completed

MaSS - Maastricht Sarcopenia Study

Role: collaborator

NCT01506557Phase 4Completed

Vitamin D Supplementation of Lactating Mothers

Role: collaborator

NCT00654719Phase 2Completed

Enteral Nutrition in Congestive Heart Failure and Cardiac Cachexia

Role: collaborator

NCT00636038Phase 1Completed

Bioavailability of Yellow Maize Carotenoids in Humans

Role: collaborator

All 5 trials loaded